Acrivon Therapeutics reported positive interim data for ACR-368 in endometrial cancer and appointed Dr. Mansoor Raza Mirza as CMO. Acrivon Therapeutics, Inc. reported promising data from its ACR-368 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback